Announcement: UEDA Heart Award for 2017

    International Heart Journal
    |December 15, 2017
    PubMed

    Insights

    This announcement highlights four award-winning cardiovascular research articles from 2017. Key studies include generating cardiomyocytes from Duchenne muscular dystrophy patients and the effects of allopurinol on heart failure.

    Area of Science:

    • Cardiovascular Research
    • Regenerative Medicine
    • Heart Failure
    • Pulmonary Hypertension

    Background:

    • The UEDA Heart Awards recognize significant contributions to cardiovascular science.
    • This selection spans diverse areas including stem cell therapy, metabolic interventions, and disease biomarkers.

    Purpose of the Study:

    • To generate induced pluripotent stem cells from Duchenne muscular dystrophy patients and differentiate them into cardiomyocytes.
    • To investigate the effect of allopurinol on myocardial energy metabolism in rats post-myocardial infarction.
    • To evaluate plasma levels of Receptor for Advanced Glycation End-Products (RAGE) and High-Mobility Group Box 1 (HMGB1) in pulmonary hypertension patients.
    • To assess the long-term cost-effectiveness of Tolvaptan in aquaporin-defined responders.

    Main Methods:

    • Generation and differentiation of induced pluripotent stem cells (iPSCs).
    • In vivo studies in rat models of chronic heart failure.
    • Measurement of plasma biomarkers using established assays.
    • Retrospective analysis of medical expenses and length of stay.

    Main Results:

    • Successful generation of cardiomyocytes from Duchenne muscular dystrophy patient-derived iPSCs.
    • Allopurinol demonstrated a positive effect on myocardial energy metabolism in heart failure rats.
    • Elevated levels of RAGE and HMGB1 were observed in pulmonary hypertension patients.
    • Tolvaptan use was associated with reduced long-term medical costs and hospital stays in specific patient groups.

    Conclusions:

    • Induced pluripotent stem cells offer a promising avenue for studying and potentially treating Duchenne muscular dystrophy.
    • Allopurinol may be a potential therapeutic agent for improving cardiac function in heart failure.
    • RAGE and HMGB1 could serve as potential biomarkers for pulmonary hypertension.
    • Tolvaptan demonstrates economic benefits in managing heart failure patients who respond to aquaporin modulation.

    Related Concept Videos

    Development of the Heart01:27

    Development of the Heart

    The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
    As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
    2.8K
    Heart Sounds01:15

    Heart Sounds

    Heart sounds are generated by the turbulence in blood flow due to the closing of heart valves. These sounds are best perceived slightly away from the valves, where the blood flow disseminates the sound.
    Auscultation is the process of listening to these internal body sounds using a stethoscope. The heart produces four types of sounds, but only two—S1 and S2—can usually be heard with a stethoscope.
    S1, also known as the "lub" sound, is caused by the closure of atrioventricular (A-V)...
    3.9K
    Location and Orientation of the Heart01:13

    Location and Orientation of the Heart

    The human heart, despite its modest size and weight, is an organ of remarkable strength and endurance. Roughly the size of a fist, the heart weighs between 250 and 350 grams and is nestled within the mediastinum, the medial cavity of the thorax. It extends obliquely for about 12 to 14 cm, resting on the superior surface of the diaphragm. The heart is positioned anterior to the vertebral column and posterior to the sternum, with two-thirds of its mass lying to the left of the midsternal line.
    11.2K
    Heart Valves01:16

    Heart Valves

    The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
    The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
    12.6K
    Cardiopulmonary Resuscitation III: AED Use01:23

    Cardiopulmonary Resuscitation III: AED Use

    Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
    781
    Overview of the Heart01:07

    Overview of the Heart

    The heart, a muscular organ located in the chest, functions as the body's pump, circulating blood through the vascular system. It has four chambers: two atria on top and two ventricles below. The right atrium receives deoxygenated blood from the body and passes it to the right ventricle, which pumps it to the lungs for oxygenation. The left atrium receives oxygenated blood from the lungs and transfers it to the left ventricle, which pumps it to the rest of the body.
    The heart's structure...
    14.4K